To ask the Scottish Executive what meetings have taken place between the UK Government and Scottish ministers on the financial impact assessment of the EU draft cross-border health care directive on Scotland.
No such meetings have taken place as any cost to Scotland in implementing the cross-border health care directive is primarily a matter for the Scottish Government.
The cost to treat patients abroad will ultimately fall on the home NHS board. The cross-border health care proposals, as they stand, state that the reimbursement to the patient cannot exceed the cost of the treatment had it been received in the home state health care system. Therefore, the cost should be limited to the expense that would have been incurred by the local NHS service provider.
The draft Directive does not seek to confer additional rights to treatment to which the patient is not entitled to receive at home. The UK Government is aware of, and agrees with, our view that it is essential that the Directive includes provision for prior authorisation from the home health care provider before a patient can travel abroad for treatment, and is negotiating on our behalf on that basis.
My officials are in the process of setting up an implementation group to inform the next stages of the negotiations and to begin to plan for implementation, including any financial impact.